My area of research and therefore my interests in science lie within genetics and molecular biology. I am especially interested in persuing the development of a therapy for EB patients and therefore focusing on an RNA-targeting therapy for RDEB, that makes it possible to repair a variety of COL7A1-associated mutations in patient-derived cells.
Hiking, reading, playing the piano, traveling, bouldering
Curriculum Vitae Julia Illmer
PhD studies in natural sciences, Paris Lodron University Salzburg
Epigenetic modifiers of disease phenotypes: epidermolysis bullosa as a paradigm
Working group: Dr. Verena Wally
Master studies: Molecular Biology at the University Salzburg.
Bachelor studies: Molecular biology at the University Salzburg.
Subject of bachelor thesis: Characterization of the conformational changes during Orai1 channel opening – concerning the positions R91 and V102 in the TM1
Supervisor: Univ.-Prof. Dr. Romanin (Biophysik Institut, Johannes Kepler Universität Linz)
Awards and Fellowships
2018 Performance scholarship – Bachelor studies Molecular biology
- Kocher T, Bischof J, Haas SA, March OP, Liemberger B, Hainzl S, Illmer J, Hoog A, Muigg K, Binder HM, Klausegger A, Strunk D, Bauer JW, Cathomen T, Koller U. A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa. Molecular Therapy - Nucleic Acids, 2021
- Ablinger M, Lettner T, Friedl N, Potocki H, Palmetzhofer T, Koller U, Illmer J, Liemberger B, Hainzl S, Klausegger A, Reisenberger M, Lambert J, Van Gele M, Desmet E, Van Maelsaeke E, Wimmer M, Zauner R, Bauer JW, Wally V. Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa. 2021;22:3326.